SKYX:NASDAQSKYX Platforms Corp. Analysis
Data as of 2026-08-14 - not real-time
$1.12
Latest Price
9/10Risk
Risk Level: High
Executive Summary
SKYX Platforms Corp. trades at $1.12, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Across the trailing 30 sessions it gained 7.7%. RSI sits at 46.6, which reads as neutral, and MACD momentum is bearish. Watch $1.06 as support and $1.37 as the nearer resistance level.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Sell-side targets cluster 260.3% above the current quote. Revenue is growing at 9.8% on a -35.8% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 88.7%, a beta of 3.25 and a maximum drawdown of 69.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Short, medium and long-term reads agree on sell, with conviction of 5/10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Sell-side targets cluster 260.3% above the current quote. Revenue is growing at 9.8% on a -35.8% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 88.7%, a beta of 3.25 and a maximum drawdown of 69.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Short, medium and long-term reads agree on sell, with conviction of 5/10.
Top Market Events
The Hotel is Part of the Shaner Hotel Group, a Prominent Hotel Developer with Over 80 Hotels in the U.MIAMI, Aug. 10, 2026 GLOBE NEWSWIRE -- SKYX Platforms Corp. NASDAQ: SKYX d/b/a SKYX Technologies the “Company” or...The Hotel is Part of the Shaner Hotel Group, a Prominent Hotel Developer with Over 80 Hotels in the U.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 4/10
Key Factors
- Trading below the 200-day average of 1.61
- MACD momentum is negative
- 30-day price change of +7.7%
Medium Term
1–3 yearsCautious
Model confidence: 4/10
Key Factors
- Trading below the 200-day average of 1.61
- Analyst targets imply +260.3% versus the current price
- 30-day volatility of 88.7%
Long Term
> 3 yearsCautious
Model confidence: 5/10
Key Factors
- Negative profit margin of -35.8%
- Analyst targets imply +260.3% versus the current price
- Negative return on equity of -239.4%
Key Metrics & Analysis
Financial Health
Revenue Growth9.80%
Profit Margin-35.79%
P/E Ratio-8.9
ROE-239.42%
ROA-26.19%
Debt/Equity151.55
P/B Ratio13.3
Op. Cash Flow$-14980416
Free Cash Flow$-1630948
Industry P/E30.9
Technical Analysis
TrendNeutral
RSI46.6
Support$1.06
Resistance$1.37
MA 20$1.17
MA 50$1.12
MA 200$1.61
MACDBearish
VolumeDecreasing
Fear & Greed Index95.98
Valuation
Target Price$4.04
Upside/Downside260.33%
GradeFair
TypeGrowth
Risk Assessment
Beta3.25
Volatility88.74%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.